Powerful Analysis Services for Genomics

Supporting researchers across a full spectrum of data analysis needs

Advance your genomic research

WuXi NextCODE delivers interpretation and actionable insights for whole genome sequencing (WGS), whole exome sequencing (WES), or transcriptome sequencing data through our Genomic Analysis Services. Advance your genomic research with our streamlined secondary and tertiary analysis services

Available Services

Learn more

Germline Variant Analysis

For singleton or family studies:

  • Secondary analysis for germline variant calling
  • Tertiary analysis
    • Comprehensive variant annotations, including population allele frequency, gene and protein, dbSNP, ClinVar, OMIM, CGD, and GO
    • Advanced research report with prioritized candidate variants related to disease

Somatic Variant Analysis

For tumor only or tumor-normal studies

  • Secondary analysis for somatic variant calling
  • Tertiary analysis
    • Comprehensive variant annotations, including COSMIC, population allele frequency, gene and protein, dbSNP, OMIM, and GO
    • Advanced research report with prioritized candidate variants related to cancer• Copy number variation (CNV)
    • Tumor mutation burden (TMB)
    • Microsatellite instability (MSI)

Purpose-built analytical suite

Comprehensive analytical suite integrated with the GORdb, the only digital platform built for population scale genomics. Analyze multi-omic and phenotypic data to identify key variants, diagnose disease, or discover new disease pathways.


DiscoveryCODE: Sequence Miner

Fast, scalable genomic and phenotypic mining tools to accelerate your research

Learn more

Clinical Sequence Analyzer

Quickly identifies clinically-relevant phenotype-associated genes and variants, all with a user-friendly interface.

Learn more

KnowledgeBASE

Built into our platform and contains information from over 50 curated reference datasets (gnomAD, OMIM, ExAC, etc.), our partnerships with multiple large genomic databanks (UK Biobank, TCGA, Simons Simplex Collection), and our own proprietary knowledge gained from working with hundreds of thousands of genomes.

Learn more